By JEFF GOLDSMITH In the first part of our look at Arnold Ventures, we explored its business model and generous support of elite University health policy experts to further an ambitious health policy agenda. In this second part, we will explore some of the questions raised by Arnold’s aggressive approach. Zack Cooper is an Associate Professor…
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets. The post The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown…
WellTheory launched a postpartum program to help women manage autoimmune symptoms triggered by hormonal changes after childbirth. The post WellTheory Introduces Autoimmune Postpartum Program appeared first on MedCity News.
The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options. The…
Let’s say that there is a very severe disease—let’s call it horriblitis—with significant impacts on patient morbidity and mortality. The only available treatment for horriblitis is drug called BlackPill. BlackPill improves health outcomes by 1 QALY over best supportive care (BSC), but costs $500,000 over the patient’s lifetime. While not cost effective by traditional standards,…
At last week’s HITLAB January 2026 Symposium, Matthew Holt gave a talk about what’s wrong with primary care, how concierge care for all can fix it, and how the most advanced primary care telehealth groups are using AI now.
In this episode, we’re joined by Anna Jeter, co-founder and chief regulatory officer of AOA Dx. We dive into AOA Dx’s recent report on women’s health exits. The post MedCity FemFwd: Why Women’s Health Is a Scalable Sector appeared first on MedCity News.
We cannot wait for CMS to hand us perfect blueprints for rehab. The time is now for rehab leaders to define what optimized care looks like, build these pathways using evidence and outcomes data, and then aggressively demonstrate that our services are the most effective way to align with the new strategic direction of healthcare….
We are only beginning to see how AI can impact women’s health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women’s needs across different life stages. The post Can AI Bridge the Gaps in Women’s Healthcare? A Responsible Path Forward appeared first on…
New KFF polling explores the challenges beyond costs that people with insurance face in navigating the health care system. People cite prior authorization review as their top problem by a wide margin, with a third (32%) saying prior authorization requirements are a “major burden.